These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1978087)

  • 1. Lack of inhibitor to monoclonal-antibody purified factor VIII concentrate.
    Lusher JM
    Lancet; 1990 Nov; 336(8725):1249-50. PubMed ID: 1978087
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient inhibitor to monoclonal antibody-purified factor VIII concentrate.
    Votaw ML; Miller S
    Am J Hematol; 1992 Dec; 41(4):297. PubMed ID: 1288295
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.
    Lusher JM
    Ann Hematol; 1991 Sep; 63(3):138-41. PubMed ID: 1932288
    [No Abstract]   [Full Text] [Related]  

  • 4. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Bergman GE
    Lancet; 1995 Nov; 346(8985):1296-7. PubMed ID: 7475737
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous infusion of monoclonal antibody-purified factor VIII.
    Weinstein RE; Bona RD; Rickles FR
    Am J Hematol; 1991 Mar; 36(3):211-2. PubMed ID: 1899966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient factor VIII inhibitor and treatment with monoclonal-antibody-purified factor VIII.
    Montoro JB; Rodríguez S; Altisent C; Tusell JM
    Lancet; 1991 May; 337(8751):1222. PubMed ID: 1673757
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Kessler C; Lusher J; Pierce GF; Pierce B; Koerper MA; Dickinson JC
    Lancet; 1995 Nov; 346(8985):1297-8. PubMed ID: 7475738
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of inhibitor to monoclonal-antibody purified FVIII concentrate.
    Mondorf W; Scharrer I
    Lancet; 1990 Sep; 336(8717):747. PubMed ID: 1975915
    [No Abstract]   [Full Text] [Related]  

  • 9. Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate.
    Mäkipernaa A; von Bonsdorff L
    Haemophilia; 2008 May; 14(3):612-4. PubMed ID: 18312362
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicentre prospective cohort study of immune function in patients treated with monoclonally immunopurified or resin-purified SNBTS high-potency factor VIII concentrate.
    Hay CR
    Transfus Sci; 1996 Sep; 17(3):337-8. PubMed ID: 10184610
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of immune response to mouse IgG in hemophilia A patients treated chronically with Monoclate, a monoclonal antibody affinity purified factor VIII preparation.
    Davis HM; Brown SK; Nash DW; Pennetti AM; Salzman PM; Schreiber AB; Haimovich J
    Thromb Haemost; 1990 Jun; 63(3):386-91. PubMed ID: 2119524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in hemophilia treatment: a hepatitis-safe factor VIII concentrate].
    Heimburger N
    Blut; 1982 Apr; 44(4):249-51. PubMed ID: 6805537
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors to monoclonal antibody purified factor VIII.
    Bell BA; Kurczynski EM; Bergman G
    Lancet; 1990 Sep; 336(8715):638. PubMed ID: 1975416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a new factor VIII concentrate in hemophilic children].
    Carnelli V; Cultrera S; Simoni L; Pasqui G; Busso B; Bagnato L
    Pediatr Med Chir; 1983; 5(3):49-55. PubMed ID: 6417627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y; Boyeldieu D; Stieltjes N
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII:C inhibitor associated with monoclonal-antibody-purified FVIII concentrate.
    Rodell MB; Bergman GE
    Lancet; 1990 Aug; 336(8711):373. PubMed ID: 1975350
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic anemia and F. VIII concentrate.
    Girelli G
    Eur J Haematol; 1989 Apr; 42(4):414. PubMed ID: 2498124
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV seroconversion in haemophilic boys receiving heat-treated factor VIII concentrate.
    Williams MD; Skidmore SJ; Hill FG
    Vox Sang; 1990; 58(2):135-6. PubMed ID: 2111060
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Hemophilia: cyclophosphamide and factor VIII concentrate.
    Stein RS
    Ann Intern Med; 1974 Nov; 81(5):706-7. PubMed ID: 4419955
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.